Trials / Unknown
UnknownNCT05738668
Clinical-immunological Features of Anti-NMDAR Encephalitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Using a retrospective cohort of 501 patients with anti-NMDAR encephalitis to assess clinical and immunological prognostic biomarkers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Description of clinical characteristic | This is a non-interventional study involving clinical data and biological samples (blood, DNA, CSF). Clinical data are collected for the center and samples are already stored in biobank repositories and collected as part of "good clinical practice" in the diagnostic process of patients with suspected autoimmune encephalitis, meaning that the standard diagnostic and therapeutic approaches will not be altered in the selected study population. Patients have already gave explicit written consent for biological specimens sampling and storage at the "Centre de Ressources Biologiques des Hospices Civils de Lyon" (CRB-HCL) (including tissue, cells or biological fluids) and genetic analysis for research purposes. Additionally, patients will be informed about the present study. |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-10-01
- Completion
- 2025-02-01
- First posted
- 2023-02-22
- Last updated
- 2023-02-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05738668. Inclusion in this directory is not an endorsement.